CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Balance exercise +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02633891
NCT02633891N/ACompleted

Metabolic Syndrome and Fall Risk

VA Office of Research and Development·interventional·Posted Dec 17, 2015·Updated Jun 28, 2024

In Brief

A clinical study evaluating Balance exercise and Standard care for Metabolic Syndrome and Autonomic Neuropathy. Completed, enrolled 12 participants across 1 site.

Detailed Summary

Obesity and the metabolic syndrome (MetS) are rapidly growing problems. Individuals with the MetS are at risk for not only future chronic diseases, but they have a higher prevalence of neuropathy, including cardiac autonomic neuropathy, and have a higher incidence of falls. Currently there are no effective therapies to prevent or reverse the neuropathy seen in the MetS or to reduced the fall risk in this population. This research project will determine if a tailored balance exercise program will have functional benefits and result in a reduced fall risk in the growing population of patients with the MetS and neuropathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 17, 2015
Enrollment StartJan 2, 2017
Primary CompletionMar 28, 2022
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 10.5 years ago

Interventions

Balance exercisebehavioral

tailored balance exercise program

Standard carebehavioral

general health education and fall prevention classes